Outcome-Adaptive Randomization: Is It Useful? von KORN, Edward L, FREIDLIN, Boris

Volltext

Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial von Von Hoff, Daniel D, Ramanathan, Ramesh K, Borad, Mitesh J, Laheru, Daniel A, Smith, Lon S, Wood, Tina E, Korn, Ronald L, Desai, Neil, Trieu, Vuong, Iglesias, Jose L, Zhang, Hui, Soon-Shiong, Patrick, Shi, Tao, Rajeshkumar, N V, Maitra, Anirban, Hidalgo, Manuel

Volltext

A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma von Banerjee, Sudeep, Wang, David S., Kim, Hyun J., Sirlin, Claude B., Chan, Michael G., Korn, Ronald L., Rutman, Aaron M., Siripongsakun, Surachate, Lu, David, Imanbayev, Galym, Kuo, Michael D.

Volltext

Randomized Clinical Trials With Biomarkers: Design Issues von Freidlin, Boris, McShane, Lisa M., Korn, Edward L.

Volltext

Statistical controversies in clinical research: assessing pathologic complete response as a trial-level surrogate end point for early-stage breast cancer von Korn, E.L., Sachs, M.C., McShane, L.M.

Volltext

Estimating contributions of indoor and outdoor sources to indoor carbonyl concentrations in three urban areas of the United States von Liu, W., Zhang, J., Zhang, L., Turpin, B.J., Weisel, C.P., Morandi, M.T., Stock, T.H., Colome, S., Korn, L.R.

Volltext

Noninvasive image texture analysis differentiates K-ras mutation from pan-wildtype NSCLC and is prognostic von Weiss, Glen J, Ganeshan, Balaji, Miles, Kenneth A, Campbell, David H, Cheung, Philip Y, Frank, Samuel, Korn, Ronald L

Volltext

Radiogenomic Analysis of Breast Cancer Using MRI: A Preliminary Study to Define the Landscape von YAMAMOTO, Shota, MAKI, Daniel D, KORN, Ronald L, KUO, Michael D

Volltext

Overall Survival As the Outcome for Randomized Clinical Trials With Effective Subsequent Therapies von KORN, Edward L, FREIDLIN, Boris, ABRAMS, Jeffrey S

Volltext

Breast Cancer Classification and Prognosis Based on Gene Expression Profiles from a Population-Based Study von Sotiriou, Christos, Neo, Soek-Ying, McShane, Lisa M., Korn, Edward L., Long, Philip M., Jazaeri, Amir, Martiat, Philippe, Fox, Steve B., Harris, Adrian L., Liu, Edison T.

Volltext

Methods for Accommodating Nonproportional Hazards in Clinical Trials: Ready for the Primary Analysis? von Freidlin, Boris, Korn, Edward L

Volltext

Design Issues of Randomized Phase II Trials and a Proposal for Phase II Screening Trials von RUBINSTEIN, Lawrence V, KORN, Edward L, FREIDLIN, Boris, HUNSBERGER, Sally, IVY, S. Percy, SMITH, Malcolm A

Volltext

Statistical and practical considerations for clinical evaluation of predictive biomarkers von Polley, Mei-Yin C, Freidlin, Boris, Korn, Edward L, Conley, Barbara A, Abrams, Jeffrey S, McShane, Lisa M

Volltext

Magnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trials von Arias-Lorza, Andrés M., Costello, James R., Hingorani, Sunil R., Von Hoff, Daniel D., Korn, Ronald L., Raghunand, Natarajan

Volltext

Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials von KORN, Edward L, LIU, Ping-Yu, PARULEKAR, Wendy, MARKOVIC, Svetomir N, SAXMAN, Scott, KIRKWOOD, John M, LEE, Sandra J, CHAPMAN, Judith-Anne W, NIEDZWIECKI, Donna, SUMAN, Vera J, MOON, James, SONDAK, Vernon K, ATKINS, Michael B, EISENHAUER, Elizabeth A

Volltext

Endpoints for randomized controlled clinical trials for COVID-19 treatments von Dodd, Lori E, Follmann, Dean, Wang, Jing, Koenig, Franz, Korn, Lisa L, Schoergenhofer, Christian, Proschan, Michael, Hunsberger, Sally, Bonnett, Tyler, Makowski, Mat, Belhadi, Drifa, Wang, Yeming, Cao, Bin, Mentre, France, Jaki, Thomas

Volltext

Randomized Phase II Trial Designs With Biomarkers von FREIDLIN, Boris, MCSHANE, Lisa M, POLLEY, Mei-Yin C, KORN, Edward L

Volltext

Platform Trials — Beware the Noncomparable Control Group von Dodd, Lori E, Freidlin, Boris, Korn, Edward L

Volltext

Augmenting randomized clinical trial data with historical control data: Precision medicine applications von Freidlin, Boris, Korn, Edward L

Volltext

Multi-Arm Clinical Trials of New Agents: Some Design Considerations von Freidlin, Boris, Korn, Edward L, Gray, Robert, Martin, Alison

Volltext